87 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... events in CKD + T2DM ... with or without T2DM ... visualabstract #table
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Medications - Comparison Table ... Side Effects: EPS/TD ... Dyslipidemia, Weight Gain/T2DM ... Profiles #Comparison #Table
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
and metformin in T2D ... sulfonylurea; T2D ... type 2 diabetes; TZD ... type 2 diabetes; TZD
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... sulfonylurea; TZD
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... patients with T2D
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Initiating Insulin for T2DM
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
patients with T2D
Type A Aortid Dissection - Suprasternal View

Type A Aortic Dissection (TAD), present on this suprasternal view
Aortic Dissection (TAD ... support type A TAD ... Aortic #Dissection #TAD ... #Notch #Aorta #POCUS
Point-of-care lung ultrasound for diagnosis of Pneumocystis jirovecii pneumonia: notes from the field
Table 3: Description of
from the field Table ... EBM #Diagnosis #POCUS